Author: Stefani Kim

Widex Appoints Alan Raffauf as VP of Marketing

Alan Raffauf comes to Widex from Oticon Medical, where since 2009, he served as Vice President of Marketing with responsibility for the go-to-market readiness and lifecycle management of bone-anchored hearing products and cochlear implants for the United States and Canada.

Read More

HearUSA to Offer Sony Over-the-Counter Hearing Aids

Responding to the Food and Drug Administration’s recent approval of over-the-counter (OTC) hearing aids, today HearUSA announced that it will offer Sony’s new over-the-counter hearing aids. The first two models – the Sony CRE-C10 and Sony CRE-E10 – will be available for clients to purchase early next year in all HearUSA centers and online, according to the announcement.

Read More

EUHA 3rd Digital Spring Conference to Take Place March 31, 2023

Lectures and live chats with the speakers will be offered in digital format on the day of the EUHA 3rd Digital Spring Conference, and will then be available on demand on the EUHA’s learning platform, “EUHA Learning Hub,” for eight weeks. Manufacturer information on new products provided by EUHA’s advertising partners completes the offer.

Read More

Nuheara Announced Partnership with InnerScope

Medical device and consumer electronics manufacturer Nuheara Limited (ASX:NUH) (Company or Nuheara) announced an expansion of its US retail footprint, from circa 300 points of sale currently to circa 4,600 over the coming months, with US FDA cleared self-fit hearing aids now being manufactured to fulfill initial orders from Best Buy and other US retail customers.

Read More

Best of ‘HR’ in 2022: Editor’s Picks

The industry has seen many changes in 2022 and it is an exciting start to my new career as Chief Editor. I am incredibly grateful to my editorial advisory board members and contributors as they continue to write content that keeps our readers at the forefront of the changes and advancements in the hearing healthcare industry. 

Read More

Widex Moment Named CES 2023 Awards Honoree

Widex announced that it has been named a CES® 2023 Innovation Awards Honoree* for the company’s Widex Moment smartphone app (iOS and Android), which is a companion to Widex Moment and the new Widex Moment Sheer. All honorees and award winners were revealed during CES Unveiled New York on November 16 – ahead of CES 2023, taking place January 5-8, 2023 in Las Vegas, Nevada. 

Read More

Sensorion Announced Orphan Drug Designation for OTOF-GT

Sensorion (FR0012596468 – ALSEN) a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to OTOF-GT, Sensorion’s lead gene therapy program, intended for the treatment of otoferlin gene-mediated hearing loss. Sensorion is on track to file a Clinical Trial Application for OTOF-GT in the first half of 2023.

Read More